Chengdu Kanghong Pharmaceutical Group Co., Ltd

XSEC:002773 Stock Report

Market Cap: CN¥18.8b

Chengdu Kanghong Pharmaceutical Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Xiao Ke

Chief executive officer

CN¥2.0m

Total compensation

CEO salary percentagen/a
CEO tenure14.4yrs
CEO ownership8.7%
Management average tenureno data
Board average tenure6.5yrs

Recent management updates

Recent updates

CEO

Xiao Ke (41 yo)

14.4yrs

Tenure

CN¥2,045,500

Compensation

Mr. Xiao Ke serves as a General Manager and President of Chengdu Kanghong Pharmaceuticals Group Co., Ltd., and Director since June 21, 2010 and served as Vice President.

Board Members

NamePositionTenureCompensationOwnership
Xiao Ke
GM, President & Director14.4yrsCN¥2.05m8.73%
CN¥ 1.6b
Jin Qun Yin
VP & Director8.2yrsCN¥5.85m0.038%
CN¥ 7.2m
Jian Rong Zhong
VP & Director16.4yrsCN¥1.43m1.15%
CN¥ 216.7m
Lin Wang
Non-Independent Director13.4yrsno datano data
Demin Zhou
Independent Director1.3yrsCN¥50.00kno data
Zhirong Zhang
Non-Independent Director1.3yrsno datano data
Jian Qun Yang
Employee Representative Supervisor4.9yrsno data0.0016%
CN¥ 307.0k
Zun Hong Ke
Chairman of the Board23.8yrsCN¥1.32m22.58%
CN¥ 4.3b
Wen Xian Gong
Chairman of the Supervisory Board13.4yrsno data3.55%
CN¥ 668.2m
Yin Ying Yang
Employee Supervisor4.9yrsno datano data
Hongguang Deng
Independent Director1.3yrsCN¥50.00kno data
Nan Xu
Independent Director1.3yrsCN¥50.00kno data

6.5yrs

Average Tenure

54yo

Average Age

Experienced Board: 002773's board of directors are considered experienced (6.5 years average tenure).